Revenio Group Oyj REVXF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $34.80
- Day Range
- $28.35–28.35
- 52-Week Range
- $28.35–44.00
- Bid/Ask
- $28.63 / $33.63
- Market Cap
- $753.55 Mil
- Volume/Avg
- 835 / 835
Key Statistics
- Price/Earnings (Normalized)
- 35.46
- Price/Sales
- 7.17
- Dividend Yield (Trailing)
- 1.43%
- Dividend Yield (Forward)
- 1.52%
- Total Yield
- 1.43%
Company Profile
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for the detection of diseases of significance to public health. Its ophthalmic diagnostic solutions includes intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, Other Europe, and Others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 216
- Website
- https://www.reveniogroup.fi
Comparables
Valuation
|
Metric
|
REVXF
|
NORDH
|
NBLY
|
|---|---|---|---|
Price/Earnings (Normalized) | 35.46 | — | 37.89 |
Price/Book Value | 6.75 | 2.92 | 1.42 |
Price/Sales | 7.17 | 6.13 | 0.95 |
Price/Cash Flow | 35.03 | 225.83 | 13.98 |
Price/Earnings
REVXF
NORDH
NBLY
Financial Strength
|
Metric
|
REVXF
|
NORDH
|
NBLY
|
|---|---|---|---|
Quick Ratio | 1.91 | 2.39 | 0.40 |
Current Ratio | 2.44 | 2.39 | 1.14 |
Interest Coverage | 60.96 | −1,270.38 | −0.27 |
Quick Ratio
REVXF
NORDH
NBLY
Profitability
|
Metric
|
REVXF
|
NORDH
|
NBLY
|
|---|---|---|---|
Return on Assets (Normalized) | 13.85% | −10.46% | −1.59% |
Return on Equity (Normalized) | 19.53% | −11.87% | −2.93% |
Return on Invested Capital (Normalized) | 18.70% | −12.17% | 0.86% |
Return on Assets
REVXF
NORDH
NBLY
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Nxdyvvqhh | Qlqdjxz | $182.3 Bil | |
SYK
| Stryker Corp | Zcydfpblc | Ntfzx | $123.5 Bil | |
MDT
| Medtronic PLC | Shtnjzrs | Wfrhmqf | $111.9 Bil | |
BSX
| Boston Scientific Corp | Mrppmlhd | Qrkbll | $108.0 Bil | |
EW
| Edwards Lifesciences Corp | Pznrjgrgyz | Fgzltmp | $52.1 Bil | |
DXCM
| DexCom Inc | Zpqrkzylc | Rmwmx | $49.5 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Bnmshyhsw | Xfdmd | $24.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Pxcskxsm | Rcvbttl | $24.5 Bil | |
ALGN
| Align Technology Inc | Vyltjrg | Lcdnc | $20.5 Bil | |
PODD
| Insulet Corp | Jrvsnvpmfd | Stpmrp | $11.3 Bil |